» Articles » PMID: 9020849

Instability of Highly Expanded CAG Repeats in Mice Transgenic for the Huntington's Disease Mutation

Overview
Journal Nat Genet
Specialty Genetics
Date 1997 Feb 1
PMID 9020849
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Six inherited neurodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar muscular atrophy (SBMA), Huntington's disease (HD), spinocerebellar ataxia type 1 (SCA1), dentatorubral pallidoluysian atrophy (DRPLA) Machado-Joseph disease (MJD or SCA3) and SCA2. Normal and expanded HD allele sizes of 6-39 and 35-121 repeats have been reported, and the allele distributions for the other diseases are comparable. Intergenerational instability has been described in all cases, and repeats tend to be more unstable on paternal transmission. This may present as larger increases on paternal inheritance as in HD, or as a tendency to increase on male and decrease on female transmission as in SCA1 (ref. 15). Somatic repeat instability is also apparent and appears most pronounced in the CNS. The major exception is the cerebellum, which in HD, DRPLA, SCA1 and MJD has a smaller repeat relative to the other brain regions tested. Of non-CNS tissues, instability was observed in blood, liver, kidney and colon. A mouse model of CAG repeat instability would be helpful in unravelling its molecular basis although an absence of CAG repeat instability in transgenic mice has so far been reported. These studies include (CAG) in the androgen receptor cDNA, (CAG) in the HD cDNA, (CAG) in the SCA1 cDNA, (CAG) in the SCA3 cDNA and as an isolated (CAG) tract.

Citing Articles

Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding.

Mathews E, Coffey S, Gartner A, Belgrad J, Bragg R, OReilly D bioRxiv. 2024; .

PMID: 39574582 PMC: 11580907. DOI: 10.1101/2024.11.04.619693.


Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models.

Hanrahan J, Locke D, Cahill L J Huntingtons Dis. 2024; 13(3):279-299.

PMID: 39213087 PMC: 11494634. DOI: 10.3233/JHD-240045.


Towards Standardizing Nomenclature in Huntington's Disease Research.

DiFiglia M, Leavitt B, Macdonald D, Thompson L J Huntingtons Dis. 2024; 13(2):119-131.

PMID: 38968054 PMC: 11307060. DOI: 10.3233/JHD-240044.


Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease.

Pengo M, Squitieri F Genes (Basel). 2024; 15(6).

PMID: 38927742 PMC: 11203031. DOI: 10.3390/genes15060807.


Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease.

Choi D, Shin J, Zeng S, Hong E, Jang J, Loupe J Elife. 2024; 12.

PMID: 38869243 PMC: 11175616. DOI: 10.7554/eLife.89782.